{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:57:58Z","timestamp":1781528278416,"version":"3.54.1"},"reference-count":11,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2026,5,19]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:p>Pancreatic neuroendocrine tumours (pNETs) are rare and can be difficult to manage due to their variable presentations. Surgical resection remains the standard treatment for symptom control and reduced risk of recurrence. Minimally invasive robotic surgery has become an alternative to open approaches due to its enhanced three-dimensional visualisation and precision. Most documented cases, however, involve solitary tumours or multifocal disease in patients with genetic syndromes such as MEN-1. We present the case of a woman in her 20s who underwent robotic subtotal pancreatectomy for multifocal pNETs, without evidence of an underlying genetic syndrome. After an uneventful postoperative recovery, the patient was discharged home on day 3. This case contributes to the limited descriptive literature on the presentation and surgical management of sporadic insulinomas.<\/jats:p>","DOI":"10.1136\/bcr-2025-270818","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:40:16Z","timestamp":1781527216000},"page":"e270818","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Robotic subtotal pancreatectomy for multifocal neuroendocrine tumour of the pancreas"],"prefix":"10.1136","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0612-2783","authenticated-orcid":false,"given":"Saif","family":"Onbargi","sequence":"first","affiliation":[{"name":"College of Medicine, University of Illinois Chicago College of Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Faraj","sequence":"additional","affiliation":[{"name":"Department of Surgery and Oncology, Clemenceau Medical Center, Dubai, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Mukherji","sequence":"additional","affiliation":[{"name":"Department of Surgery and Oncology, Clemenceau Medical Center, Dubai, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"2026061505401075000_19.6.e270818.1","doi-asserted-by":"crossref","first-page":"101294","DOI":"10.1016\/j.beem.2019.101294","article-title":"Pre- and intraoperative diagnostic requirements, benefits and risks of minimally invasive and robotic surgery for neuroendocrine tumors of the pancreas","volume":"33","author":"Gharios","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2026061505401075000_19.6.e270818.2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i28.4036"},{"key":"2026061505401075000_19.6.e270818.3","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i6.829"},{"key":"2026061505401075000_19.6.e270818.4","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/XCS.0000000000000307","article-title":"Comparison Between Sporadic and Multiple Endocrine Neoplasia Type 1-Associated Insulinoma","volume":"235","author":"Sada","year":"2022","journal-title":"J Am Coll Surg"},{"key":"2026061505401075000_19.6.e270818.5","unstructured":"National Comprehensive Cancer Network . NCCN clinical practice guidelines in oncology: Neuroendocrine and adrenal tumors (Version 3.2025). 2025. Available: www.nccn.org"},{"key":"2026061505401075000_19.6.e270818.6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084041","article-title":"Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1","volume":"22","author":"Marini","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026061505401075000_19.6.e270818.7","first-page":"e25","article-title":"Surgical Management of Pancreatic Neuroendocrine Tumors","volume":"40","author":"Sulciner","year":"2024","journal-title":"J Clin Oncol Oncol Pract"},{"key":"2026061505401075000_19.6.e270818.8","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-23-0034","article-title":"Pathological features in non-neoplastic congenital and adult hyperinsulinism: from nesidioblastosis to current terminology and understanding","volume":"30","author":"Sempoux","year":"2023","journal-title":"Endocr Relat Cancer"},{"key":"2026061505401075000_19.6.e270818.9","doi-asserted-by":"crossref","DOI":"10.1186\/s12893-018-0376-5","article-title":"Robotic enucleation for pediatric insulinoma with MEN1 syndrome: a case report and literature review","volume":"18","author":"Liang","year":"2018","journal-title":"BMC Surg"},{"key":"2026061505401075000_19.6.e270818.10","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-009-0825-4"},{"key":"2026061505401075000_19.6.e270818.11","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3182a4e87c"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2025-270818","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:40:19Z","timestamp":1781527219000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2025-270818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":11,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,15]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/bcr-2025-270818"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2025-270818","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}